ASPIRE BIOPHARMA HOLDINGS, INC. Other Current Liabilities
ASPIRE BIOPHARMA HOLDINGS, INC. (ASBP) had Other Current Liabilities of $353.68 thousand as of 2025-12-31, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Liabilities › Liabilities, Current
us-gaap:OtherLiabilitiesCurrent · last filed 2026-08-13
- 2025-12-31: Other Liabilities, Current $353.68K.
- 2025-03-31: Other Liabilities, Current $353.68K.
- 2025-02-17: Other Liabilities, Current $353.68K.
- 2024-12-31: Other Liabilities, Current $111.03K; Other Liabilities, Current as first filed $358.94K.
| Period end | Other Liabilities, Current | Other Liabilities, Current as first filed |
|---|---|---|
| 2025-12-31 | $353.68K 10-Q · filed 2026-08-13 | |
| 2025-03-31 | $353.68K 10-Q/A · filed 2025-08-13 | |
| 2025-02-17 | $353.68K 10-Q · filed 2026-05-15 | |
| 2024-12-31 | $111.03K S-1/A · filed 2026-04-10 | $358.94K 10-K · filed 2025-04-07 |
| 2024-09-30 | $328.94K 10-Q · filed 2024-11-14 | |
| 2024-06-30 | $298.94K 10-Q · filed 2024-08-16 | |
| 2024-03-31 | $268.94K 10-Q · filed 2024-06-05 | |
| 2023-12-31 | $238.94K 10-K · filed 2025-04-07 | |
| 2023-09-30 | $211.94K 10-Q · filed 2023-11-08 | |
| 2023-06-30 | $182.69K 10-Q · filed 2023-08-08 | |
| 2022-12-31 | $122.69K 10-K · filed 2024-03-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| BIOVIE INC. (BIVI) | United States | $0.012B | |
| Tempest Therapeutics, Inc. (TPST) | United States | $0.013B | |
| ADIAL PHARMACEUTICALS, INC. (ADIL) | United States | $0.012B | |
| Phio Pharmaceuticals Corp. (PHIO) | United States | $0.012B | -0.92 |
| AEON Biopharma, Inc. (AEON) | United States | $0.013B | -0.36 |
| Scienture Holdings, Inc. (SCNX) | United States | $0.012B | -0.38 |
| MUSTANG BIO, INC. (MBIO) | United States | $0.013B | |
| Vistagen Therapeutics, Inc. (VTGN) | United States | $0.013B | -0.14 |
| KIORA PHARMACEUTICALS INC (KPRX) | United States | $0.012B | |
| Dare Bioscience, Inc. (DARE) | United States | $0.011B |